UniQure's UQ1.F experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study, it said on Wednesday. Huntington's is a rare ...

UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...

Jenna Cotromano shares how a Huntington’s disease diagnosis at 18 changed her life and why she now uses social media to ...

This image shows three brain cells with the faulty protein that causes Huntington’s disease. The bright yellow cell in the middle has built up a clump of this protein inside it. The blue spots in the ...

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory, and personality. It is caused by a toxic protein that builds in brain cells and ultimately kills them.

Researchers have implicated a new gene in the progression of Huntington's disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. Six ...

WASHINGTON — Scientists have uncovered a clue about why it takes so long for Huntington’s disease to develop. And they may have a lead on how to stop the fatal brain disease. Huntington’s is caused by ...

BUFFALO, N.Y. — A decade ago, University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington’s disease?

An experimental treatment for the first time slowed the devastating progression of Huntington’s disease, gene therapy company uniQure announced Wednesday, a rare hopeful advance against a cruel ...

A chloroplast enzyme safeguards plants against pathological protein aggregation that causes Huntington’s and other neurodegenerative diseases. New research may have found a way to 'copy' the mechanism ...

Beta-blocker use was tied with slower symptom progression in people with early motor-manifest Huntington's disease. In a people with genetically confirmed premanifest Huntington's, beta-blocker use ...